Speculation that the recent human rabies deaths in the State might have been due to the poor quality of anti-rabies vaccine and serum administered to the victims has been partially laid to rest, with the State receiving information that the samples of rabies immunoglobulin serum sent to the Central Drug Laboratories (CDL) have cleared the quality tests. The results of the anti-rabies vaccine samples sent from the State to CDL for quality testing are awaited.
The widespread speculation that the quality of biologicals (vaccine and immunoglobulin serum) used for rabies treatment in the State might be suspect rose following the death of six persons, who contracted human rabies following dog bites despite having been administered the anti-rabies vaccine and serum (vaccination was partial in the case of one person).
